The University of Chicago Header Logo

Connection

Richard Whitley to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Richard Whitley has written about Antiviral Agents.
Richard Whitley
Connection Strength
15.822
Antiviral Agents
  1. Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat? Pediatr Infect Dis J. 2019 06; 38(6S Suppl 1):S60-S63.
    View in: PubMed
    Score: 0.521
  2. Genital Herpes. N Engl J Med. 2016 11 10; 375(19):1906.
    View in: PubMed
    Score: 0.436
  3. CLINICAL PRACTICE. Genital Herpes. N Engl J Med. 2016 Aug 18; 375(7):666-74.
    View in: PubMed
    Score: 0.430
  4. Accelerating Drug Development: Antiviral Therapies for Emerging Viruses as a Model. Annu Rev Pharmacol Toxicol. 2017 01 06; 57:155-169.
    View in: PubMed
    Score: 0.427
  5. Oseltamivir for influenza - Authors' reply. Lancet. 2016 Jan 09; 387(10014):125.
    View in: PubMed
    Score: 0.412
  6. Oseltamivir for influenza - Authors' reply. Lancet. 2015 Sep 19; 386(9999):1135-6.
    View in: PubMed
    Score: 0.403
  7. The development of new therapies for human herpesvirus 6. Curr Opin Virol. 2014 Dec; 9:148-53.
    View in: PubMed
    Score: 0.379
  8. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials. Antivir Ther. 2015; 20(7):709-19.
    View in: PubMed
    Score: 0.378
  9. A novel potential therapy for HSV. N Engl J Med. 2014 Jan 16; 370(3):273-4.
    View in: PubMed
    Score: 0.359
  10. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2013 May; 56(9):1197-205.
    View in: PubMed
    Score: 0.335
  11. The use of antiviral drugs during the neonatal period. Clin Perinatol. 2012 Mar; 39(1):69-81.
    View in: PubMed
    Score: 0.313
  12. Antiviral drugs and antiviral drug resistance. Curr Opin Virol. 2011 Dec; 1(6):545-7.
    View in: PubMed
    Score: 0.309
  13. Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis. Pediatr Infect Dis J. 2011 Oct; 30(10):860-5.
    View in: PubMed
    Score: 0.306
  14. Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012 Jan; 53(1):6-11.
    View in: PubMed
    Score: 0.304
  15. Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol. 2011; 697:221-30.
    View in: PubMed
    Score: 0.291
  16. Treatment of herpes simplex virus infections in pediatric patients: current status and future needs. Clin Pharmacol Ther. 2010 Nov; 88(5):720-4.
    View in: PubMed
    Score: 0.286
  17. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother. 2009 May; 63(5):862-7.
    View in: PubMed
    Score: 0.257
  18. Therapy of herpes virus infections in children. Adv Exp Med Biol. 2008; 609:216-32.
    View in: PubMed
    Score: 0.236
  19. The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol. 2007 Oct; 3(5):755-67.
    View in: PubMed
    Score: 0.232
  20. Review of recent HSV recurrent-infection treatment studies. Herpes. 2007 Jun; 14(1):23-6.
    View in: PubMed
    Score: 0.227
  21. Current non-AIDS antiviral chemotherapy. Expert Rev Anti Infect Ther. 2007 Apr; 5(2):217-30.
    View in: PubMed
    Score: 0.224
  22. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
    View in: PubMed
    Score: 0.220
  23. Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006 Nov 01; 43(9):1194-7.
    View in: PubMed
    Score: 0.216
  24. New approaches to the therapy of HSV infections. Herpes. 2006 Aug; 13(2):53-5.
    View in: PubMed
    Score: 0.214
  25. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. 2006 Jul; 50(7):2409-14.
    View in: PubMed
    Score: 0.213
  26. Single-day famciclovir therapy for recurrent genital herpes. Curr Med Res Opin. 2006 Jul; 22(7):1307-10.
    View in: PubMed
    Score: 0.213
  27. Commentary: Ch'ien LT, Cannon NJ, Charamella LJ, et al. effect of adenine arabinoside on severe herpesvirus hominis infections in man: preliminary report. J Infect Dis 1973; 128:658-63. J Infect Dis. 2004 Oct 01; 190(7):1360-7.
    View in: PubMed
    Score: 0.189
  28. Neonatal herpes simplex virus infection. Curr Opin Infect Dis. 2004 Jun; 17(3):243-6.
    View in: PubMed
    Score: 0.184
  29. Clinical practice. Herpes zoster. N Engl J Med. 2002 Aug 01; 347(5):340-6.
    View in: PubMed
    Score: 0.162
  30. Herpes simplex virus infection. Semin Pediatr Infect Dis. 2002 Jan; 13(1):6-11.
    View in: PubMed
    Score: 0.156
  31. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001 Feb; 20(2):127-33.
    View in: PubMed
    Score: 0.146
  32. Herpes zoster: focus on treatment in older adults. Antiviral Res. 1999 Dec 31; 44(3):145-54.
    View in: PubMed
    Score: 0.136
  33. Cytomegalovirus retinitis--evolving therapies in a new era. N Engl J Med. 1999 Apr 08; 340(14):1109-10.
    View in: PubMed
    Score: 0.129
  34. Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999 Jan; 179(1):9-15.
    View in: PubMed
    Score: 0.127
  35. Therapeutic approaches to the management of herpes zoster. Adv Exp Med Biol. 1999; 458:159-65.
    View in: PubMed
    Score: 0.127
  36. Approaches to the treatment of varicella-zoster virus infections. Contrib Microbiol. 1999; 3:158-72.
    View in: PubMed
    Score: 0.127
  37. Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Res. 1998 Dec; 40(1-2):73-84.
    View in: PubMed
    Score: 0.126
  38. Clinical management of herpes simplex virus infections: past, present, and future. F1000Res. 2018; 7.
    View in: PubMed
    Score: 0.125
  39. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
    View in: PubMed
    Score: 0.121
  40. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother. 1998 May; 42(5):1139-45.
    View in: PubMed
    Score: 0.121
  41. Summary of the III International Consensus Symposium on Combined Antiviral Therapy. Antiviral Res. 1998 May; 38(2):75-93.
    View in: PubMed
    Score: 0.121
  42. Antiviral therapy for neonatal herpes simplex virus: a cost-effectiveness analysis. Am J Manag Care. 1997 Oct; 3(10):1551-8.
    View in: PubMed
    Score: 0.116
  43. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997 May; 175(5):1080-6.
    View in: PubMed
    Score: 0.113
  44. Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol. 1997 Mar; 24(1):267-83.
    View in: PubMed
    Score: 0.111
  45. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res. 1997 Jan; 33(2):73-85.
    View in: PubMed
    Score: 0.110
  46. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 1996 Sep 01; 125(5):376-83.
    View in: PubMed
    Score: 0.108
  47. The past as prelude to the future: history, status, and future of antiviral drugs. Ann Pharmacother. 1996 Sep; 30(9):967-71.
    View in: PubMed
    Score: 0.108
  48. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs. J Virol Methods. 1996 Apr 26; 58(1-2):137-43.
    View in: PubMed
    Score: 0.105
  49. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J. 1996 Mar; 15(3):247-54.
    View in: PubMed
    Score: 0.104
  50. Antiviral resistance: mechanisms, clinical significance, and future implications. J Antimicrob Chemother. 1996 Mar; 37(3):403-21.
    View in: PubMed
    Score: 0.104
  51. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996 Feb; 22(2):341-7.
    View in: PubMed
    Score: 0.103
  52. Sorivudine: a potent inhibitor of varicella zoster virus replication. Adv Exp Med Biol. 1996; 394:41-4.
    View in: PubMed
    Score: 0.103
  53. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection. Neurology. 1995 Dec; 45(12 Suppl 8):S73-5.
    View in: PubMed
    Score: 0.102
  54. Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis. 2015 Sep 01; 61(5):683-91.
    View in: PubMed
    Score: 0.098
  55. A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis. J Pediatric Infect Dis Soc. 2016 Mar; 5(1):53-62.
    View in: PubMed
    Score: 0.098
  56. Antiviral resistance--an emerging problem. Antiviral Res. 1995 Apr; 26(4):365-8.
    View in: PubMed
    Score: 0.098
  57. Molecular mechanisms of antiviral resistance. Antiviral Res. 1995 Apr; 26(4):369-401.
    View in: PubMed
    Score: 0.098
  58. Assays for antiviral drug resistance. Antiviral Res. 1995 Apr; 26(4):403-13.
    View in: PubMed
    Score: 0.098
  59. Models of antiviral resistance. Antiviral Res. 1995 Apr; 26(4):415-22.
    View in: PubMed
    Score: 0.098
  60. Antiviral resistance in clinical practice. Antiviral Res. 1995 Apr; 26(4):423-38.
    View in: PubMed
    Score: 0.098
  61. Research initiatives in studies of antiviral resistance and consensus points and recommendations. Antiviral Res. 1995 Apr; 26(4):439-52.
    View in: PubMed
    Score: 0.098
  62. Challenges and opportunities in developing respiratory syncytial virus therapeutics. J Infect Dis. 2015 Mar 15; 211 Suppl 1:S1-S20.
    View in: PubMed
    Score: 0.097
  63. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015 Mar 05; 372(10):933-43.
    View in: PubMed
    Score: 0.097
  64. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015 May 02; 385(9979):1729-1737.
    View in: PubMed
    Score: 0.096
  65. Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med. 2014 Aug 21; 371(8):711-22.
    View in: PubMed
    Score: 0.094
  66. The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep; 96(3):380-9.
    View in: PubMed
    Score: 0.092
  67. Antiviral therapy: the time has come. J Med Virol. 1993; Suppl 1:1.
    View in: PubMed
    Score: 0.084
  68. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis. 1992 Aug; 166 Suppl 1:S51-7.
    View in: PubMed
    Score: 0.081
  69. Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. J Virol. 2012 May; 86(9):5304-13.
    View in: PubMed
    Score: 0.079
  70. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011 Oct 06; 365(14):1284-92.
    View in: PubMed
    Score: 0.077
  71. Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis. 2010 Aug 15; 202(4):563-6.
    View in: PubMed
    Score: 0.071
  72. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol. 2010 May; 48 Suppl 1:S20-8.
    View in: PubMed
    Score: 0.069
  73. Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J. 2010 Mar; 29(3):195-8.
    View in: PubMed
    Score: 0.069
  74. Novel pharmacological strategies in the treatment of life-threatening cytomegalovirus infections. Clinical experience with continuous infusion 9-(1,3-dihydroxy-2-propoxymethyl) guanine. Ann N Y Acad Sci. 1990; 616:452-60.
    View in: PubMed
    Score: 0.068
  75. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrob Agents Chemother. 2009 Dec; 53(12):5251-8.
    View in: PubMed
    Score: 0.067
  76. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec; 46 Suppl 4:S22-6.
    View in: PubMed
    Score: 0.066
  77. A 70-year-old woman with shingles: review of herpes zoster. JAMA. 2009 Jul 01; 302(1):73-80.
    View in: PubMed
    Score: 0.065
  78. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007. Herpes. 2008 Oct; 15(1):4-12.
    View in: PubMed
    Score: 0.062
  79. Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clin Infect Dis. 2008 Apr 01; 46(7):1024-31.
    View in: PubMed
    Score: 0.060
  80. Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections? Ann Intern Med. 1988 Mar; 108(3):452-4.
    View in: PubMed
    Score: 0.060
  81. The frustrations of treating herpes simplex virus infections of the central nervous system. JAMA. 1988 Feb 19; 259(7):1067.
    View in: PubMed
    Score: 0.060
  82. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes. 2007 Sep; 14 Suppl 2:25-9.
    View in: PubMed
    Score: 0.058
  83. The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001. Clin Infect Dis. 2007 Oct 01; 45(7):881-2.
    View in: PubMed
    Score: 0.058
  84. An update on short-course intermittent and prevention therapies for herpes labialis. Herpes. 2007 Jun; 14 Suppl 1:13A-18A.
    View in: PubMed
    Score: 0.057
  85. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun; 81(6):867-72.
    View in: PubMed
    Score: 0.056
  86. Antiviral therapy and pulmonary disease. Chest. 1987 Feb; 91(2):246-51.
    View in: PubMed
    Score: 0.055
  87. Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract. 2007 Jan; 56(1):30-6.
    View in: PubMed
    Score: 0.055
  88. Approaches to therapy of viral infections. Adv Pediatr. 1987; 34:89-110.
    View in: PubMed
    Score: 0.055
  89. Therapy of viral infections in children. Adv Pediatr Infect Dis. 1987; 2:35-56.
    View in: PubMed
    Score: 0.055
  90. Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S155-61.
    View in: PubMed
    Score: 0.054
  91. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006 Sep; 71(2-3):141-8.
    View in: PubMed
    Score: 0.053
  92. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol. 2006 Mar; 194(3):774-81.
    View in: PubMed
    Score: 0.052
  93. Neonatal herpes should be a reportable disease. Sex Transm Dis. 2005 Sep; 32(9):521-5.
    View in: PubMed
    Score: 0.050
  94. Therapy for human herpesvirus infections. A perspective. Ala J Med Sci. 1985 Apr; 22(2):193-207.
    View in: PubMed
    Score: 0.049
  95. Human herpesvirus 6 infection of the central nervous system: is it just a case of mistaken association? Clin Infect Dis. 2005 Mar 15; 40(6):894-5.
    View in: PubMed
    Score: 0.048
  96. Neonatal herpes: what have we learned. Semin Pediatr Infect Dis. 2005 Jan; 16(1):7-16.
    View in: PubMed
    Score: 0.048
  97. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004 Nov 01; 39(9):1307-13.
    View in: PubMed
    Score: 0.047
  98. Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. 1973. J Infect Dis. 2004 Oct 01; 190(7):1362-7.
    View in: PubMed
    Score: 0.047
  99. HSV shedding. Antiviral Res. 2004 Aug; 63 Suppl 1:S19-26.
    View in: PubMed
    Score: 0.047
  100. HSV-2 transmission. Antiviral Res. 2004 Aug; 63 Suppl 1:S27-35.
    View in: PubMed
    Score: 0.047
  101. Treatment of human herpesvirus infections with special reference to encephalitis. J Antimicrob Chemother. 1984 Aug; 14 Suppl A:57-74.
    View in: PubMed
    Score: 0.047
  102. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003 Jul; 143(1):16-25.
    View in: PubMed
    Score: 0.043
  103. Towards therapy and prevention of herpetic infections. Semin Perinatol. 1983 Jan; 7(1):64-81.
    View in: PubMed
    Score: 0.042
  104. Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med. 1982 Jul 20; 73(1A):236-40.
    View in: PubMed
    Score: 0.040
  105. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Am J Med. 1982 Jul 20; 73(1A):165-71.
    View in: PubMed
    Score: 0.040
  106. Herpesvirus infections in childhood: diagnostic dilemmas and therapy. Pediatr Infect Dis. 1982 Mar-Apr; 1(2):81-4.
    View in: PubMed
    Score: 0.039
  107. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002 Feb 09; 359(9305):507-13.
    View in: PubMed
    Score: 0.039
  108. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med. 2001 Aug 30; 20(16):2429-39.
    View in: PubMed
    Score: 0.038
  109. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001 Aug; 108(2):223-9.
    View in: PubMed
    Score: 0.038
  110. Herpes simplex virus infections. Lancet. 2001 May 12; 357(9267):1513-8.
    View in: PubMed
    Score: 0.037
  111. Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother. 1980 Nov; 18(5):709-15.
    View in: PubMed
    Score: 0.036
  112. Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis. Antiviral Res. 1999 Nov; 44(1):75-8.
    View in: PubMed
    Score: 0.034
  113. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol. 1999 Mar; 127(3):329-39.
    View in: PubMed
    Score: 0.032
  114. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol. 1998 Oct; 179(4):846-51.
    View in: PubMed
    Score: 0.031
  115. Current status of antiviral chemotherapy. South Med J. 1978 Sep; 71(9):1134-40.
    View in: PubMed
    Score: 0.031
  116. Developmental aspects of selected antiviral chemotherapeutic agents. Annu Rev Microbiol. 1978; 32:285-300.
    View in: PubMed
    Score: 0.030
  117. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res. 1997 Apr 15; 57(8):1502-9.
    View in: PubMed
    Score: 0.028
  118. Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. Antiviral Res. 1996 Nov; 32(3):119-40.
    View in: PubMed
    Score: 0.027
  119. Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother. 1996 Sep; 40(9):2202-5.
    View in: PubMed
    Score: 0.027
  120. Treatment of infections due to Herpesvirus in humans: a critical review of the state of the art. J Infect Dis. 1976 Jun; 133 Suppl:A101-8.
    View in: PubMed
    Score: 0.026
  121. Advances in the management of herpesvirus infections. Introduction. Semin Dermatol. 1996 Jun; 15(2 Suppl 1):1-3.
    View in: PubMed
    Score: 0.026
  122. Therapy of herpetic infections in man: a status report. Adv Pathobiol. 1976; (5):159-72.
    View in: PubMed
    Score: 0.026
  123. Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host. Antiviral Res. 1996 Jan; 29(1):67-8.
    View in: PubMed
    Score: 0.026
  124. Neonatal herpes simplex virus infection. Int Ophthalmol Clin. 1975; 15(4):141-9.
    View in: PubMed
    Score: 0.024
  125. A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents. J Virol Methods. 1994 Jul; 48(2-3):273-9.
    View in: PubMed
    Score: 0.023
  126. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci U S A. 1994 Mar 29; 91(7):2441-7.
    View in: PubMed
    Score: 0.023
  127. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med. 1993 Oct 07; 329(15):1065-72.
    View in: PubMed
    Score: 0.022
  128. Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1. Antiviral Res. 1993 Apr; 20(4):293-303.
    View in: PubMed
    Score: 0.021
  129. Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1. Antiviral Res. 1992 Sep; 19(3):181-92.
    View in: PubMed
    Score: 0.020
  130. Humanized antibodies for antiviral therapy. Proc Natl Acad Sci U S A. 1991 Apr 01; 88(7):2869-73.
    View in: PubMed
    Score: 0.018
  131. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus. Pediatr Infect Dis J. 1989 Sep; 8(9):584-5.
    View in: PubMed
    Score: 0.017
  132. Neonatal herpes simplex virus infections. Clin Perinatol. 1988 Dec; 15(4):903-16.
    View in: PubMed
    Score: 0.016
  133. Herpesvirus infections in the immunocompromised host: diagnosis and management. Adv Exp Med Biol. 1986; 202:95-118.
    View in: PubMed
    Score: 0.013
  134. Preventive and therapeutic approaches to the newborn infant with perinatal viral and toxoplasma infections. Clin Perinatol. 1981 Oct; 8(3):591-604.
    View in: PubMed
    Score: 0.010
  135. Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs. 1980 Oct; 20(4):267-82.
    View in: PubMed
    Score: 0.009
  136. Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther. 1979 Dec; 26(6):718-28.
    View in: PubMed
    Score: 0.008
  137. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol. 1998 Aug; 36(8):2229-34.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.